Clinical Trials Insight: 700038511
Phase of Trial: Phase I
Latest Information Update: 30 Oct 2009
At a glance
- Drugs PHX-1766 (Primary)
- Indications Chronic hepatitis; Hepatitis C
- Focus Adverse reactions; Pharmacokinetics
- Sponsors Phenomix Corporation
- 30 Oct 2009 Status changed from recruiting to completed, based on results reported at the AASLD meeting.
- 30 Oct 2009 Results reported at 60th Annual Meeting of the American Association of the Study of Liver Diseases.
- 07 Nov 2008 New trial record.